|
1
|
Higginson DS, Morris DE, Jones EL, et al:
Stereotactic body radiotherapy (SBRT): technological innovation and
application in gynecologic oncology. Gynecol Oncol. 120:404–412.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guckenberger M, Bachmann J, Wulf J, et al:
Stereotactic body radiotherapy for local boost irradiation in
unfavourable locally recurrent gynaecological cancer. Radiother
Oncol. 94:53–59. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Deodato F, Macchia G, Grimaldi L, et al:
Stereotactic radiotherapy in recurrent gynecological cancer: A case
series. Oncol Rep. 22:415–419. 2009.PubMed/NCBI
|
|
4
|
Habermehl D, Herfarth KK, Bermejo JL, et
al: Single-dose radiosurgical treatment for hepatic metastases -
therapeutic outcome of 138 treated lesions from a single
institution. Radiat Oncol. 8:1752013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Seung SK, Larson DA, Galvin JM, et al:
American College of Radiology (ACR) and American Society for
Radiation Oncology (ASTRO) practice guideline for the performance
of stereotactic radiosurgery (SRS). Am J Clin Oncol. 36:310–315.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Solberg TD, Balter JM, Benedict SH, et al:
Quality and safety considerations in stereotactic radiosurgery and
stereotactic body radiation therapy: executive summary. Pract
Radiat Oncol. 2:2–9. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Potters L, Kavanagh B, Galvin JM, et al:
American Society for Therapeutic Radiology and Oncology (Astro) and
American College of Radiology (ACR) practice guideline for the
performance of stereotactic body radiation therapy. Int J Radiat
Oncol Biol Phys. 76:326–332. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Molla M, Escude L, Nouet P, et al:
Fractionated stereotactic radiotherapy boost for gynecologic
tumors: an alternative to brachytherapy? Int J Radiat Oncol Biol
Phys. 62:118–124. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kunos C, Chen W, DeBernardo R, et al:
Stereotactic body radiosurgery for pelvic relapse of gynecologic
malignancies. Technol Cancer Res Treat. 8:393–400. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kunos CA, Brindle J, Waggoner S, et al:
Phase II clinical trial of robotic stereotactic body radiosurgery
for metastatic gynecologic malignancies. Front Oncol. 2:1812012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kunos CA and Spelic M: Role of
stereotactic radiosurgery in gynecologic cancer. Curr Opin Oncol.
25:532–538. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jorcano S, Molla M, Escude L, et al:
Hypofractionated extracranial stereotactic radiotherapy boost for
gynecologic tumors: a promising alternative to high-dose rate
brachytherapy. Technol Cancer Res Treat. 9:509–514. 2010.
View Article : Google Scholar
|
|
13
|
Choi CW, Cho CK, Yoo SY, et al:
Image-guided stereotactic body radiation therapy in patients with
isolated para-aortic lymph node metastases from uterine cervical
and corpus cancer. Int J Radiat Oncol Biol Phys. 74:147–153. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Otto K: Volumetric modulated arc therapy:
IMRT in a single gantry arc. Med Phys. 35:310–317. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Deodato F, Cilla S, Macchia G, et al:
Extracranial radiosurgery with volumetric modulated arc therapy:
Feasibility evaluation of a phase I trial. Oncol Lett. 5:1889–1896.
2013.PubMed/NCBI
|
|
16
|
Macchia G, Morganti AG, Cilla S, et al:
Quality of life and toxicity of stereotactic radiotherapy in
pancreatic tumors: a case series. Cancer Invest. 30:149–155. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hurkmans CW, Cuijpers JP, Lagerwaard FJ,
et al: Recommendations for implementing stereotactic radiotherapy
in peripheral stage IA non-small cell lung cancer: report from the
quality assurance working party of the randomised phase III ROSEL
study. Radiat Oncol. 4:12009. View Article : Google Scholar
|
|
18
|
Cilla S, Viola P, Azario L, et al:
Comparison of measured and computer portal dose for IMRT treatment.
J Appl Clin Med Phys. 7:65–79. 2006.PubMed/NCBI
|
|
19
|
Morganti AG, Deodato F, Zizzari S, et al:
Complexity index (COMIX) and not type of treatment predicts
undetected errors in radiotherapy planning and delivery. Radiother
Oncol. 89:320–329. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Therasse P, Arbuck SG, Eisenhauer EA, et
al: New guidelines to evaluate the response to treatment in solid
tumors. European Organization for Research and Treatment of Cancer,
National Cancer Institute of the United States, National Cancer
Institute of Canada. J Natl Cancer Inst. 92:205–216. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Young H, Baum R, Cremerius U, et al:
Measurement of clinical and subclinical response using
[18F]-fluorodeoxiglucose and positron emission tomography: review
and 1999 EORTC recommendations. European Organisation for Research
and Treatment of Cancer (EORTC) PET study group. Eur J Cancer.
35:1773–1782. 1999.
|
|
22
|
National Institutes of Health National
Cancer Institute. Common Terminology Criteria for Adverse Events
(CTCAE), version 4.03. Published on February 22, 2012.
|
|
23
|
Sutherland HJ, Walker P and Till JE: The
development of a method for determining oncology patients’
emotional distress using linear analogue scales. Cancer Nurs.
11:303–308. 1988.
|
|
24
|
Melzack R: The McGill pain questionnaire:
major properties and scoring methods. Pain. 1:277–299. 1975.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Salazar OM, Sandhu T, da Motta NW, et al:
Fractionated half-body irradiation (HBI) for the rapid palliation
of widespread, symptomatic, metastatic bone disease: a randomized
phase III trial of the International Atomic Energy Agency (IAEA).
Int J Radiat Oncol Biol Phys. 50:765–775. 2001. View Article : Google Scholar
|
|
26
|
Kaplan EL and Meier P: Non-parametric
estimation from incomplete observations. J Am Statist Assoc.
53:457–481. 1985. View Article : Google Scholar
|
|
27
|
Mayr NA, Huang Z, Sohn JW, et al: Emerging
application of stereotactic body radiation therapy for gynecologic
malignancies. Expert Rev Anticancer Ther. 11:1069–1075.
2011.PubMed/NCBI
|
|
28
|
Grigsby PW: Radiotherapy for pelvic
recurrence after radical hysterectomy for cervical cancer. Radiat
Med. 23:327–330. 2005.PubMed/NCBI
|
|
29
|
Haasbeek CJ, Uitterhoeve AL, van der
Velden J, et al: Long-term results of salvage radiotherapy for the
treatment of recurrent cervical carcinoma after prior surgery.
Radiother Oncol. 89:197–204. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ito H, Shigematsu N, Kawada T, et al:
Radiotherapy for centrally recurrent cervical cancer of the vaginal
stump following hysterectomy. Gynecol Oncol. 67:154–161. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guckenberger M, Wulf J, Mueller G, et al:
Dose-response relationship for image-guided stereotactic body
radiotherapy of pulmonary tumors: relevance of 4D dose calculation.
Int J Radiat Oncol Biol Phys. 74:47–54. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rusthoven KE, Kavanagh BD, Cardenes H, et
al: Multi-institutional phase I/II trial of stereotactic body
radiation therapy for liver metastases. J Clin Oncol. 27:1572–1578.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rusthoven KE, Kavanagh BD, Burri SH, et
al: Multi-institutional phase I/II trial of stereotactic body
radiation therapy for lung metastases. J Clin Oncol. 27:1579–1584.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mendez Romero A, Wunderink W, Hussain SM,
et al: Stereotactic body radiation therapy for primary and
metastatic liver tumors: a single institution phase i–ii study.
Acta Oncol. 45:831–837. 2006.
|
|
35
|
Herfarth KK, Debus J, Lohr F, et al:
Stereotactic single-dose radiation therapy of liver tumors: results
of a phase I/II trial. J Clin Oncol. 19:164–170. 2001.PubMed/NCBI
|
